HUNTINGTON — A new concept in cancer treatment will be future explored at Marshall University thanks to a grant from the National Cancer Institute.
The U.S. Department of Health and Human Services (HHS) National Cancer Institute awarded a $432,369 three-year Academic Research Enhancement Award to the Marshall University Joan C. Edwards School of Medicine to launch a cancer biology research project in “epigenetics,” a relatively new concept in cancer therapies, according to a press release from Rep. Nick Rahall, D-W.Va.
The concept deals with a new chemotheraputic target in cancer treatment, said Dr. Vincent E. Sollars, an associate professor of biochemistry and biology at Marshall.
“It’s a great way for me and the students to get involved in some research I’ve wanted to do for some time,” Sollars said. “We’re targeting leukemia specifically with this grant, but the this could have ramifications on all types of cancers.”
Over the course of the three-year project, Marshall University anticipates involving eight students from undergraduate, master’s and doctoral academic programs, as well as students enrolled in the med school.
Sollars said the medical school also will hire a full time technician through the grant.